Media Contact:
Dan Budwick
Pure Communications, Inc.
(973) 271-6085

OpGen, Inc., to Present at the Piper Jaffray 22nd Annual Health Care Conference

Gaithersburg, Md. – November 30, 2010 – OpGen, Inc. a commercial phase genomics company, today announced that Douglas White, chief executive officer, is scheduled to present at the Piper Jaffray 22nd Annual Health Care Conference on Wednesday, Dec. 1, 2010, at 1:30 p.m. in New York City.

About OpGen, Inc.
OpGen, Inc. is a leading innovator in the field of microbial genetics. The company has developed a platform for its proprietary Optical Mapping Technology. Optical Mapping is the first technology that bridges strain typing and sequencing to correlate phenotype to genotype for generating advances in fields such as biodefense, outbreak management, agriculture and clinical microbiology. The Argus™ Optical Mapping System and MapIt™ Optical Mapping Services deliver ordered, whole genome genetic maps from single DNA molecules. The platform provides automated, high resolution, whole genome analysis for strain typing, comparative genomics and sequence assembly of microbial genomes to the life sciences market. This de novo technology is free from the limitations of gel, PCR and sequencing-based methodologies and has broad molecular diagnostic applications that are currently in development. OpGen’s customers include biodefense organizations, leading genomic research centers, academic institutions, clinical research organizations and biotechnology companies. For more information, visit www.gbbetasite.com/opgen.